Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
- PMID: 32017047
- PMCID: PMC7317937
- DOI: 10.1002/bjs.11476
Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
Abstract
Background: Conditional survival accounts for the time already survived after surgery and may be of additional informative value. The aim was to assess conditional survival in patients with oesophageal cancer and to create a nomogram predicting the conditional probability of survival after oesophagectomy.
Methods: This retrospective study included consecutive patients with oesophageal cancer who received neoadjuvant chemoradiation followed by oesophagectomy between January 2004 and 2019. Conditional survival was defined as the probability of surviving y years after already surviving for x years. The formula used for conditional survival (CS) was: CS(x|y) = S(x + y) /S(x) , where S(x) represents overall survival at x years. Cox proportional hazards models were used to evaluate predictors of overall survival. A nomogram was constructed to predict 5-year survival directly after surgery and given survival for 1, 2, 3 and 4 years after surgery.
Results: Some 660 patients were included. Median overall survival was 44·4 (95 per cent c.i. 37·0 to 51·8) months. The probability of achieving 5-year overall survival after resection increased from 45 per cent directly after surgery to 54, 65, 79 and 88 per cent given 1, 2, 3 and 4 years already survived respectively. Cardiac co-morbidity, cN category, ypT category, ypN category, chyle leakage and pulmonary complications were independent predictors of survival. The nomogram predicted 5-year survival using these predictors and number of years already survived.
Conclusion: The probability of achieving 5-year overall survival after oesophagectomy for cancer increases with each additional year survived. The proposed nomogram predicts survival in patients after oesophagectomy, taking the years already survived into account.
Antecedentes: La supervivencia condicional hace referencia al tiempo ya sobrevivido tras la cirugía y esta información puede tener un valor adicional. El objetivo fue evaluar la supervivencia condicional en pacientes con cáncer de esófago y crear un nomograma para predecir la probabilidad condicional de supervivencia tras una esofaguectomía. MÉTODOS: Estudio retrospectivo incluyó pacientes consecutivos con cáncer de esófago que fueron tratados con quimiorradioterapia neoadyuvante seguida de cirugía, entre enero de 2004 a 2019, en el centro médico de la Universidad de Amsterdam (AMC) de los Países Bajos. La supervivencia condicional se definió como la probabilidad de sobrevivir y años tras haber ya sobrevivido ya durante x años. La formula utilizada fue: CS(x|y) =S(x+y) /S(x) , con S(x) representando la supervivencia global a x años. Se utilizaron modelos de riesgo proporcional de Cox para evaluar los predictores de supervivencia global. Se construyó un nomograma para predecir la supervivencia a los 5 años directamente tras la cirugía y dar la supervivencias a 1-, 2-, 3- y 4 años después de la cirugía.
Resultados: Se incluyeron 660 pacientes. La mediana de la supervivencia global fue de 44,4 meses (i.c. del 95% 37,0-51,8). La probabilidad de conseguir una supervivencia global a los 5 años tras la resección aumentó del 45% directamente después de la cirugía al 54%, 65%, 79% y 88% por cada año adicional sobrevivido. La comorbilidad cardiaca, estadio cN, estadio ypT, estadio ypN, quilotórax y complicaciones pulmonares fueron predictores independientes de supervivencia. El nomograma predijo la supervivencia a 5 años utilizando estos predictores y número de años ya sobrevividos. CONCLUSIÓN: La probabilidad de alcanzar una supervivencia global a los 5 años tras una esofaguectomía por cáncer aumenta por cada año adicional sobrevivido. El nomograma propuesto predice la supervivencia en pacientes después de una esofaguectomía, teniendo en cuenta los años ya sobrevividos.
© 2020 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.
Figures
Similar articles
-
Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.Eur J Surg Oncol. 2021 Dec;47(12):3175-3181. doi: 10.1016/j.ejso.2021.06.010. Epub 2021 Jun 6. Eur J Surg Oncol. 2021. PMID: 34120806
-
Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.Br J Surg. 2016 Dec;103(13):1864-1873. doi: 10.1002/bjs.10304. Epub 2016 Sep 30. Br J Surg. 2016. PMID: 27689845
-
External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.Ann Surg Oncol. 2020 Apr;27(4):1250-1258. doi: 10.1245/s10434-019-08024-0. Epub 2019 Nov 5. Ann Surg Oncol. 2020. PMID: 31691114 Free PMC article.
-
[Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].Zentralbl Chir. 2014 Feb;139(1):32-6. doi: 10.1055/s-0033-1360295. Epub 2014 Feb 28. Zentralbl Chir. 2014. PMID: 24585195 Review. German.
-
Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile?Arch Surg. 1998 Jul;133(7):722-6. doi: 10.1001/archsurg.133.7.722. Arch Surg. 1998. PMID: 9687999 Review.
Cited by
-
Dynamic estimates of survival in oncocytic cell carcinoma of the thyroid.Discov Oncol. 2023 Nov 30;14(1):217. doi: 10.1007/s12672-023-00839-4. Discov Oncol. 2023. PMID: 38030805 Free PMC article.
-
Long-Term Survival Associated with Direct Oral Feeding Following Minimally Invasive Esophagectomy: Results from a Randomized Controlled Trial (NUTRIENT II).Cancers (Basel). 2023 Oct 5;15(19):4856. doi: 10.3390/cancers15194856. Cancers (Basel). 2023. PMID: 37835550 Free PMC article.
-
Racial disparities in conditional survival of patients with bladder cancer: a population-based study.BMC Urol. 2023 Jul 18;23(1):122. doi: 10.1186/s12894-023-01293-8. BMC Urol. 2023. PMID: 37464352 Free PMC article.
-
Conditional survival nomogram for monitoring real-time survival of young non-metastatic nasopharyngeal cancer survivors.J Cancer Res Clin Oncol. 2023 Sep;149(12):10181-10188. doi: 10.1007/s00432-023-04952-3. Epub 2023 Jun 2. J Cancer Res Clin Oncol. 2023. PMID: 37266664
-
Prognosis and conditional nomogram of cervical spine fracture in patients with severe spinal cord injury: a multicenter retrospective study.Int J Surg. 2023 May 1;109(5):1271-1280. doi: 10.1097/JS9.0000000000000365. Int J Surg. 2023. PMID: 36999783 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917. - PubMed
-
- Gupta B, Kumar N. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev 2017; 26: 107–118. - PubMed
-
- World Health Organization . Esophageal cancer: statistics https://www.cancer.net/cancer‐types/esophageal‐cancer/statistics [accessed 18 December 2018].
-
- Buderi SI, Shackcloth M, Page RD. Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer? Interact Cardiovasc Thorac Surg 2017; 24: 115–120. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
